1. Home
  2. HALO vs ALV Comparison

HALO vs ALV Comparison

Compare HALO & ALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • ALV
  • Stock Information
  • Founded
  • HALO 1998
  • ALV 1953
  • Country
  • HALO United States
  • ALV Sweden
  • Employees
  • HALO N/A
  • ALV N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • ALV Auto Parts:O.E.M.
  • Sector
  • HALO Health Care
  • ALV Consumer Discretionary
  • Exchange
  • HALO Nasdaq
  • ALV Nasdaq
  • Market Cap
  • HALO 7.4B
  • ALV 7.2B
  • IPO Year
  • HALO N/A
  • ALV 1997
  • Fundamental
  • Price
  • HALO $52.02
  • ALV $101.93
  • Analyst Decision
  • HALO Buy
  • ALV Buy
  • Analyst Count
  • HALO 9
  • ALV 11
  • Target Price
  • HALO $63.56
  • ALV $114.64
  • AVG Volume (30 Days)
  • HALO 3.1M
  • ALV 569.2K
  • Earning Date
  • HALO 05-06-2025
  • ALV 04-16-2025
  • Dividend Yield
  • HALO N/A
  • ALV 2.74%
  • EPS Growth
  • HALO 55.40
  • ALV 35.84
  • EPS
  • HALO 3.76
  • ALV 8.68
  • Revenue
  • HALO $1,084,306,000.00
  • ALV $10,353,000,000.00
  • Revenue This Year
  • HALO $24.79
  • ALV N/A
  • Revenue Next Year
  • HALO $22.65
  • ALV $3.78
  • P/E Ratio
  • HALO $13.83
  • ALV $11.76
  • Revenue Growth
  • HALO 25.64
  • ALV N/A
  • 52 Week Low
  • HALO $41.28
  • ALV $75.49
  • 52 Week High
  • HALO $70.51
  • ALV $129.38
  • Technical
  • Relative Strength Index (RSI)
  • HALO 39.78
  • ALV 70.29
  • Support Level
  • HALO $47.50
  • ALV $100.05
  • Resistance Level
  • HALO $69.94
  • ALV $102.40
  • Average True Range (ATR)
  • HALO 3.52
  • ALV 1.72
  • MACD
  • HALO -1.49
  • ALV 0.90
  • Stochastic Oscillator
  • HALO 19.64
  • ALV 91.21

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About ALV Autoliv Inc.

Autoliv Inc is the world-wide leader in passive safety components and systems for the auto industry. Products include seat belts, frontal air bags, side-impact air bags, air bag inflators, and steering wheels. The Renault-Nissan-Mitsubishi alliance is the company's largest customer at 10% of 2023 revenue, with Stellantis accounting for 10% and Volkswagen 9%. At 34% of 2023 revenue, the Americas was Autoliv's largest geographic region, followed by Europe at 27%, China at 20%, and rest of world at 19%.

Share on Social Networks: